IPO - Future Cardia, Inc.

Form Type: 253G2

Filing Date: 2025-06-24

Corporate Action: Ipo

Type: New

Accession Number: 000121390025057236

Filing Summary: Future Cardia, Inc., a medical device technology startup founded in May 2019, is pursuing an Initial Public Offering (IPO) of up to 5,000,000 shares of common stock along with 1,000,000 bonus shares. The offering, set to commence following SEC qualification, aims to raise a maximum of $18,525,000. Investors must meet a minimum investment threshold of $360.18, which includes transaction fees. In exchange for the investment, the company will require investors to grant a proxy for share voting rights to the Chief Executive Officer, resulting in limited influence for investors over corporate matters. Despite successfully implanting devices in 39 patients for cardiac monitoring, the company reported substantial net losses of over $4.6 million for two consecutive years and faces significant risks surrounding capital acquisition for continued operations and FDA approval processes for its devices. The document outlines several key risks associated with investing, including possible loss of investment and the speculative nature of the offering, which is conducted on a 'best-efforts' basis, meaning there is no minimum fundraising target. The offering aims to leverage current market opportunities in the growing U.S. medical device market, particularly related to heart failure management.

Form Type: 1-A/A

Filing Date: 2025-02-24

Corporate Action: Ipo

Type: New

Accession Number: 000121390025016563

Filing Summary: Future Cardia, Inc. is filing a form 1-A/A to offer up to 5,000,000 shares of Common Stock at a price of $3.1050 per share. Additionally, the company will issue up to 1,000,000 bonus shares of Common Stock to certain investors at no additional cost. This offering relates to equity under Tier 2 of Regulation A. The document includes various financial figures and information regarding convertible notes and options to purchase common stock.